SEC 13F Intelligence

Venrock Adviser, LLC / OCUL

Venrock Adviser, LLC’s Ocular Therapeutix Inc Position

Does Venrock Adviser, LLC own Ocular Therapeutix Inc (OCUL)? Yes — 10.35M shares worth $88M (+3.27% of its 13F portfolio) as of Q1 2026, up from 7.32M shares the prior filed quarter.

Position Value
$88M
Q1 2026
Shares
10.35M
% of Portfolio
+3.27%
Quarters Held
10
currently held

Position History OCUL

Reported value by quarter
Q4 ’23: $35MQ4 ’23Q1 ’24: $116MQ2 ’24: $87MQ2 ’24Q3 ’24: $111MQ4 ’24: $109MQ4 ’24Q1 ’25: $94MQ2 ’25: $118MQ2 ’25Q3 ’25: $154MQ4 ’25: $89MQ4 ’25Q1 ’26: $88Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202610.35M$88M+3.27%
Q4 20257.32M$89M+4.39%
Q3 202513.16M$154M+8.66%
Q2 202512.76M$118M+8.88%
Q1 202512.76M$94M+7.96%
Q4 202412.76M$109M+7.48%
Q3 202412.76M$111M+5.82%
Q2 202412.76M$87M+5.56%
Q1 202412.76M$116M+5.52%
Q4 20237.78M$35M+2.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venrock Adviser, LLC’s full portfolio or all institutional holders of OCUL.